Society for Translational Oncology

Society for Translational Oncology Our mission is to promote high-quality, equitable healthcare through innovative education and collaborative global efforts.

STO advances global oncology and patient care by bridging scientific discovery and clinical application, promoting equitable healthcare, and harmonizing cancer trials and regulatory standards to ensure swift access to life-saving treatments worldwide. Society for Translational Oncology: A Global Mission
The Society for Translational Oncology (STO), a 501(c)(3) not-for-profit organization, is dedicated to advancing global oncology and improving patient care by bridging the gap between scientific discovery and clinical application. Committed to diversity, inclusivity, and equity, STO empowers healthcare professionals with the knowledge and tools to implement cutting-edge cancer therapies and improve patient outcomes worldwide. Through strategic guidance and global alliances, we work to harmonize cancer clinical trials and regulatory standards, ensuring that life-saving treatments are speedily accessible to all patients with cancer. STO Continuing Medical Education Mission
STO is committed to providing impactful education to oncology physicians, with the goal of improving the quality and safety of care for patients with cancer. This mission will be fulfilled by offering relevant and effective continuing medical education programs, focusing on:
Knowledge and strategies for implementation of critical new developments in cancer treatment, screening, and prevention
The translational gap between research, discovery and delivery of care to the patient, providing content that is evidence-based and within the discipline of clinical medicine
Educational activities that are relevant and impact the practice of physicians within an oncology team in collaboration with nurses, pharmacists and other oncology healthcare professionals

We are proud to support Cancer Prevention & Early Detection Month! Preventing cancer or detecting it early can lead to  ...
04/01/2026

We are proud to support Cancer Prevention & Early Detection Month! Preventing cancer or detecting it early can lead to .

Learn more, raise awareness & stand with us: https://bit.ly/3Ob5VAP

03/16/2026

"No thank you, not today." 😔

We've all heard that response in clinic. But here's the game-changer: swap "You can get the HPV vaccine if you'd like" for "Today I strongly recommend the HPV cancer-prevention vaccine" and families say YES far more often.

Our new April article shares the exact words that work:

✅ Presumptive phrasing clinicians can use immediately
✅ "Try this, avoid this" examples
✅ How to make HPV prevention feel routine

Routine recommendations aren't pushy. They save lives.

Read the full guide and start using these phrases tomorrow: https://bit.ly/4uz1vYi 👇

What HPV conversation tips have worked best in your practice?

03/04/2026
Every year on International HPV Awareness Day, the message is clear: Ask about HPV. Learn the facts. Take action.HPV is ...
03/04/2026

Every year on International HPV Awareness Day, the message is clear: Ask about HPV. Learn the facts. Take action.
HPV is a preventable cause of multiple cancers. We have effective vaccines. We have screening tools. Yet too often, awareness does not translate into completed vaccination, timely screening, or reliable follow-up.
In our latest blog, STO explores what it takes to turn awareness into action and why well-designed, equitable systems are essential to preventing HPV-related cancers.
Are we ready when people ask?
Read the full blog here: https://buff.ly/WLy9ijZ

Awareness starts the conversation. Systems determine the outcome. As the “Ask About HPV” campaign gains momentum, this piece examines how health systems can turn questions into action and convert…

When cancer screening “works,” it can look deceptively simple: test, result, follow‑up, treatment. In reality, every ste...
02/18/2026

When cancer screening “works,” it can look deceptively simple: test, result, follow‑up, treatment. In reality, every step is fragile, especially for people facing social and structural barriers.

Our latest article explores how patient navigation holds those steps together, shortens time to diagnosis and treatment, and turns equity from an aspiration into a design feature of cancer systems, not an afterthought.

Read more: https://buff.ly/qE5mdiA

When cancer prevention and screening programs succeed, success often appears effortless. A person gets screened, results are delivered, follow-up happens, and treatment begins when needed. In practice…

02/05/2026

is a powerful reminder of the progress being made in cancer care and the impact it continues to have every day 💙

New projections highlight rising cancer diagnoses, alongside meaningful gains in survival thanks to advances in prevention, early detection, and treatment. At the same time, proposed cuts to NCI funding could influence the future of cancer research and care.

Explore the latest data and insights on what this means for oncology nurses and APPs 🔬📊
https://hubs.li/Q041QCgm0

02/04/2026

Today is World Cancer Day.

Cervical cancer is one of the most preventable cancers, yet it continues to take hundreds of thousands of lives every year.

The science is clear. What matters now is ensuring vaccines, screening, and treatment reach every woman, no matter where she lives.

That’s where implementation — not just innovation — makes the difference.

Every story matters. But too often, cancer care systems overlook the realities of people’s lives.This World Cancer Day, ...
02/03/2026

Every story matters. But too often, cancer care systems overlook the realities of people’s lives.

This World Cancer Day, United by Unique invites us to reflect on what person-centered cancer care really means, and why equity requires more than good intentions. Our latest STO blog explores what it takes to make care work in the real world. https://buff.ly/FDAuGxZ

Imagine a woman in rural North Carolina who has just received an abnormal cervical screening result. She may need to delay her follow-up, not because she fears the procedure, but because her car won’t…

Cervical cancer prevention is at a turning point. The tools work. Now the challenge is implementing them in ways that re...
01/21/2026

Cervical cancer prevention is at a turning point. The tools work. Now the challenge is implementing them in ways that reach more women and ensure follow-up care.

HPV testing with self-collection can expand access and improve equity, especially in low-resource settings. But its impact depends on strong clinical workflows, clear referral pathways, and timely treatment.

Our latest article explores what it takes to make self-sampled HPV testing work at scale. Learn more on - https://buff.ly/KiW4Tum

As efforts to eliminate cervical cancer accelerate, attention is shifting from whether screening tools are effective to how they are implemented in routine care. The field is moving beyond a narrative…

A new international study highlighted in STAT points to a major breakthrough in cervical cancer prevention: a single dos...
12/05/2025

A new international study highlighted in STAT points to a major breakthrough in cervical cancer prevention: a single dose of the HPV vaccine may provide protection comparable to the traditional two-dose schedule.

This has significant implications for global health. A one-dose strategy could make vaccination more accessible, reduce costs, and help reach individuals in communities where completing multi-dose series is challenging.

Cervical cancer remains one of the most preventable cancers and expanding HPV vaccination is a critical step toward closing the equity gap worldwide.

Read more: https://www.statnews.com/2025/12/04/hpv-vaccine-single-shot-cervical-cancer-prevention/

A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported in a new study.

ChatGPT demonstrates efficiency in clinical trial recruitment https://buff.ly/cMlROFKAI-assisted trial recruitment: prom...
10/27/2025

ChatGPT demonstrates efficiency in clinical trial recruitment https://buff.ly/cMlROFK

AI-assisted trial recruitment: promising, but not perfect.

A new study in Machine Learning: Health evaluated how ChatGPT (GPT-3.5 and GPT-4) performs in identifying eligible patients for a head and neck cancer trial.

🔹 GPT-4 outperformed GPT-3.5 (AUC 0.838 vs 0.761) in identifying eligible patients
🔹 Structured prompts + expert guidance improved accuracy
🔹 GPT-4 was slower and costlier (7.9–12.4 min, ~$0.15–$0.27 per screen), but still efficient at scale
🔹 Best use case: AI to narrow candidates → clinician to confirm eligibility

Dr. Michael Dohopolski (UT Southwestern) noted that while LLMs can’t yet interpret nuanced clinical criteria, they can dramatically reduce manual workload in screening electronic health records.

As AI evolves, these tools could become valuable adjuncts for research teams facing limited personnel and time pressures, provided models remain HIPAA-compliant and clinician oversight stays central.

Multiple versions of ChatGPT demonstrated efficacy in identifying eligible patients for clinical trial recruitment, showing potential to complement manual chart reviews, according to a study published in Machine Learning: Health.Improving clinical trial recruitment has been an ongoing challenge in t...

Explore 10 significant events in the history of breast cancer. Discover more here: https://buff.ly/E4AC4xz
10/27/2025

Explore 10 significant events in the history of breast cancer. Discover more here: https://buff.ly/E4AC4xz

Our understanding of breast cancer has evolved significantly since it was first documented nearly 5,000 years ago. Explore some of the many milestones in the history of breast cancer research and treatment.

Address

Durham, NC

Alerts

Be the first to know and let us send you an email when Society for Translational Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram